{"id":2717,"date":"2014-04-19T15:56:32","date_gmt":"2014-04-19T15:56:32","guid":{"rendered":"https:\/\/www.corporatediplomacy.com\/?p=2717"},"modified":"2014-04-19T15:56:32","modified_gmt":"2014-04-19T15:56:32","slug":"reputation-risk-for-big-phrma","status":"publish","type":"post","link":"https:\/\/www.corporatediplomacy.com\/reputation-risk-for-big-phrma\/","title":{"rendered":"Reputation risk for big PhRMA"},"content":{"rendered":"<p><a href=\"http:\/\/www.ft.com\/intl\/cms\/s\/0\/10bb1972-c170-11e3-83af-00144feabdc0.html?siteedition=intl#axzz2zKxrndxn\">FT story<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>FT story<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[27,26],"tags":[45,53],"_links":{"self":[{"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/posts\/2717"}],"collection":[{"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/comments?post=2717"}],"version-history":[{"count":1,"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/posts\/2717\/revisions"}],"predecessor-version":[{"id":2718,"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/posts\/2717\/revisions\/2718"}],"wp:attachment":[{"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/media?parent=2717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/categories?post=2717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.corporatediplomacy.com\/wp-json\/wp\/v2\/tags?post=2717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}